Elotuzumab, Selinexor, and Dexamethasone for Relapsed Refractory Multiple Myeloma

Clinical trial NCT05170789 · WITHDRAWN

Trial details

NCT number: NCT05170789
Sponsor: Tulane University School of Medicine
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsed Multiple Myeloma Refractory Multiple Myeloma

Start date: 2022-04-27
Primary completion: 2022-04-27
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.